MILLENNIUM MANAGEMENT LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$3,638
-87.8%
866,152
-82.5%
0.00%
-88.2%
Q4 2022$29,826
-99.9%
4,962,769
+4.4%
0.02%
+6.2%
Q3 2022$27,669,000
+46.3%
4,754,128
+50.1%
0.02%
+33.3%
Q2 2022$18,913,000
+85.9%
3,168,087
+45.4%
0.01%
+140.0%
Q1 2022$10,174,000
+1891.0%
2,178,563
+956.8%
0.01%
Q4 2021$511,000
-51.2%
206,147
-41.9%
0.00%
-100.0%
Q3 2021$1,048,000
+47.4%
355,099
+24.9%
0.00%
Q2 2021$711,000
-43.9%
284,216
-34.8%
0.00%
-100.0%
Q1 2021$1,268,000
+3.1%
435,600
+14.0%
0.00%0.0%
Q4 2020$1,230,000
+1632.4%
382,055
+528.4%
0.00%
Q2 2020$71,000
+108.8%
60,798
+65.3%
0.00%
Q1 2020$34,000
+100.0%
36,780
+238.2%
0.00%
Q4 2019$17,000
-90.6%
10,876
-95.0%
0.00%
Q3 2019$181,000
-69.5%
218,484
-68.3%
0.00%
-100.0%
Q2 2019$593,000
-82.4%
689,551
+1.9%
0.00%
-75.0%
Q2 2018$3,370,000
+9.8%
676,755
-14.0%
0.00%0.0%
Q1 2018$3,068,000
+1327.0%
786,583
+1067.9%
0.00%
Q3 2017$215,000
-67.8%
67,352
-57.7%
0.00%
-100.0%
Q1 2017$668,000159,1200.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders